Posted by Michael Wonder on 22 Jan 2019
In oversight inquiry, key Democrat seeking 10 years’ worth of pricing, sales, research data from drug companies
22 January 2019 - Republican Elijah Cummings, the Maryland Democrat chairing the House Oversight Committee, put the pharmaceutical industry on notice this week when he launched an investigation into the industry’s drug pricing tactics.
Until now, we didn’t know much more than the names of the 12 companies he sent letters to.
